Engaging chromatin: PRC2 structure meets function
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Chammas, Paul, 1992-
- dc.contributor.author Mocavini, Ivano
- dc.contributor.author Di Croce, Luciano
- dc.date.accessioned 2020-04-03T07:28:41Z
- dc.date.issued 2020
- dc.description.abstract Polycomb repressive complex 2 (PRC2) is a key epigenetic multiprotein complex involved in the regulation of gene expression in metazoans. PRC2 is formed by a tetrameric core that endows the complex with histone methyltransferase activity, allowing it to mono-, di- and tri-methylate histone H3 on lysine 27 (H3K27me1/2/3); H3K27me3 is a hallmark of facultative heterochromatin. The core complex of PRC2 is bound by several associated factors that are responsible for modulating its targeting specificity and enzymatic activity. Depletion and/or mutation of the subunits of this complex can result in severe developmental defects, or even lethality. Furthermore, mutations of these proteins in somatic cells can be drivers of tumorigenesis, by altering the transcriptional regulation of key tumour suppressors or oncogenes. In this review, we present the latest results from structural studies that have characterised PRC2 composition and function. We compare this information with data and literature for both gain-of function and loss-of-function missense mutations in cancers to provide an overview of the impact of these mutations on PRC2 activity.
- dc.format.mimetype application/pdf
- dc.identifier.citation Chammas P, Mocavini I, Di Croce L. Engaging chromatin: PRC2 structure meets function. Br J Cancer. 2020; 122(3):315-28. DOI: 10.1038/s41416-019-0615-2
- dc.identifier.doi http://dx.doi.org/10.1038/s41416-019-0615-2
- dc.identifier.issn 0007-0920
- dc.identifier.uri http://hdl.handle.net/10230/44155
- dc.language.iso eng
- dc.publisher Nature Research
- dc.relation.ispartof Br J Cancer. 2020; 122(3):315-28
- dc.rights © Springer Nature Publishing AG Chammas P, Mocavini I, Di Croce L. Engaging chromatin: PRC2 structure meets function. Br J Cancer. 2020; 122(3):315-28. DOI: 10.1038/s41416-019-0615-2 [http://dx.doi.org/10.1038/s41416-019-0615-2]
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.subject.keyword Cancer
- dc.subject.keyword Epigenetics
- dc.title Engaging chromatin: PRC2 structure meets function
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/acceptedVersion